A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval
NCT ID: NCT00794183
Last Updated: 2012-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
EARLY_PHASE1
25 participants
INTERVENTIONAL
2004-06-30
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The setting we propose to adjust is the timing between the impulse sent between top and bottom chambers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
NCT01466621
Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT Indications
NCT03071978
Survey of QRS Frequency at Various Left Ventricular Pacing Sites for Cardiac Resynchronization
NCT03253809
Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy
NCT02083419
Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders
NCT05760924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are blood tests (often referred to as "markers") that give us information about how well your heart is working and about how your body is responding to heart failure. The idea of this study is to compare different ways of setting up a pacemaker, using these blood tests to give us information about how well it's working. We hope to learn if we can use this approach to figure out the best pacemaker setup ("programming") for each individual patient.
Usually pacemakers have two wires or leads, one is in the top right chamber and the other in the bottom right chamber of the heart. The newer pacemakers, which are given to patients with heart failure, have an additional lead or wire, which goes to the left side of the heart. So when heart contracts the lead from top chamber sends impulses to bottom chambers and the leads in right and left sides of bottom chamber responds by sending impulses in a co-ordinated way enabling heart to contract efficiently.
Currently, the standard way of treating patients with heart failure is by pacing the top and then bottom chambers, based on a timing interval determined by ultrasound, while also pacing the two bottom chambers in a coordinated manner. There are differences of opinion among experts and by previous studies regarding this method. Pacing is accomplished through pacemaker wires, which are placed in the right top chamber, the right bottom chamber and the left bottom chamber of the heart.
The setting we propose to adjust is the timing between the impulse sent between top and bottom chambers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
AVD set by taking the larger of 0.50ms or A-V interval 0.30
CRT device settings
Comparision of A-V delay settings
2
AVD set by taking the larger of 0.50ms or A-V interval 0.50
CRT device settings
Comparision of A-V delay settings
3
AVD set by taking the larger of 0.50ms or A-V interval 0.70
CRT device settings
Comparision of A-V delay settings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CRT device settings
Comparision of A-V delay settings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients on stable pharmacologic therapy for at least 3 months
* EF\< 35%
* age \>18 years
* NYHA functional class III or IV
* eligible for either CRT pacer or CRT defibrillator for heart failure
* Ischemic or non-ischemic cardiomyopathy
* patients that are able to tolerate VDD mode with a lower rate of 40bpm programming
Exclusion Criteria
* Likely to receive a left ventricular assist device or cardiac transplant within 6 months of implant procedure
* patients who have previously received a CRT device
* documented atrial fibrillation
* complete heart block
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minnesota Medical Foundation
OTHER
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David G Benditt, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0303M44604
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.